All of Us Pennsylvania Research Program
You may be able to change the future of medicine. The All of Us PA Research Program is enrolling adults 18 years of age or older. This may be your chance to improve how your children and your children’s children receive medical care.
MyPaTH Story Booth: Amplifying African American Voices and Healthcare Experiences
In follow-up of Black History Month, the Story Booth team is putting a special focus on stories from African American storytellers over the next 90 days. We would like to invite patients, caregivers, and health care providers to share their experiences regarding accessing health care. Your voices can empower change to research, patient-centered care, and most importantly, your community.
MyPaTH Story Booth – COVID-19 Stories
Participants are invited to share how they are maintaining their health during the coronavirus pandemic, or to share what it is like being ill with COVID-19 and/or caring for a loved one who is ill with COVID-19. Participation in this research study involves one 45-minute session that takes place over the phone. Eligible participants must be able to read and understand English.
MyPaTH Story Booth 2.0
Interested in sharing your story about health, illness, or research? Patients and caregivers are needed to participate in a research study to help learn more about topics that are important to you and that may improve health and health care. Participation involves one 45-minute session that takes place over the phone. Eligible participants must be able to read and understand English.
Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy
Are you newly seeking treatment for heroin or other opioids? Are you 18 or older? You may be eligible for a research study to test treatment approaches, including medications, to help patients with opioid use disorder stay in treatment.
Cocaine Users – CRF-NOP Brain Imaging Study
Cocaine users between 18-50 years old are needed for a brain imaging research study to help learn more about the role of a protein in cocaine use. Participation involves questionnaires, interviews, brain scanning (1 MRI and 2 PET scans), and the administration of intravenous hydrocortisone. Compensation provided.
Brain Imaging Research Study – Cocaine Users
Do you currently use cocaine or have you recently used cocaine? Are you aged 18–55? You may be able to participate in a research study to help learn more about two proteins in the brain that may play a role in substance use disorders. Compensation is provided.
Neuro Study for Pregnant Women in an Opioid Replacement Therapy Program
Are you currently pregnant and taking Subutex (Buprenorphine), Suboxone, or Methadone? You may be able to participate in a study to evaluate the effects of these medications on the fetal and newborn baby’s brain. There are four parts to this study, and you may choose to participate in one or more parts. Compensation is provided for all parts of the study.
Cannabis Reactions, Effects, Acute Thoughts, and Experiences (CREATE) Study
Do you use cannabis? If you are between the ages of 18 to 25 and use cannabis at least weekly, you may be eligible to participate in a research study. The CREATE Study examines cannabis use, mood, experiences, and behaviors in the lab and throughout your day. We offer evening hours and weekends for study visits to fit your schedule.
Q-PRONTO Research Study – Pregnant and on MAT
Are you in your third trimester of pregnancy (at least 28 weeks pregnant)? Are you currently on medication-assisted treatment (MAT) for opioid use disorder? You may be able to participate in a study to evaluate third trimester and postpartum pain sensitivity in patients with and without history of opioid use. This study involves 2 visits lasting about 1 hour total. Compensation is provided.
CTN-0080 MOMs Study
Are you a pregnant woman who uses opioids or is currently prescribed Suboxone, Subutex, or Zubsolv? You may be able to participate in a research study to compare the safety and effectiveness of two different forms of buprenorphine for pregnant women and their unborn children. The study begins while you are pregnant and continues until 12 months after you have given birth. Compensation is provided.